Artificial Intelligence: A Promising Tool to Manage Clinical Studies during Fertility

Abstract

Artificial intelligence (AI) may be an additional catalytic instrument to manage several diseases and disorders. This review article aims to address the significant intervention of AI to manage fertility-associated clinical symptoms. Several challenges in pregnancy research lie in the necessity to consider the welfare and interests of fertile parents. In addition to that, there are several challenges to developing, designing and delivering the new drugs intended for pregnant women. Some of the AI tools perform specific subtasks within the clinical trial design process to enhance the overall performance of clinical trials. Thus, by adhering to the AI approach which can be gradually integrated into the clinical trial ecosystem. This review has also examined the difficulties that emerge when conducting trials that are intended for use during pregnancy and childhood and further, AI techniques can act as potential strategies for mitigating adverse drug reactions during trial sessions. However, Various ethical and regulatory guidelines are set up for effective trial management.